Enbridge Equity Method Investments decreased by 0.2% to $21.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $20.69B to $21.26B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 9.0% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.36B | $13.49B | $13.32B | $13.36B | $13.69B | $15.35B | $15.94B | $16.32B | $15.26B | $15.27B | $16.79B | $17.44B | $18.23B | $18.30B | $20.69B | $20.98B | $20.79B | $21.31B | $21.26B |
| QoQ Change | — | +1.0% | -1.2% | +0.3% | +2.4% | +12.1% | +3.8% | +2.4% | -6.5% | +0.1% | +10.0% | +3.8% | +4.5% | +0.4% | +13.1% | +1.4% | -0.9% | +2.5% | -0.2% |
| YoY Change | — | — | — | — | +2.5% | +13.8% | +19.6% | +22.1% | +11.5% | -0.5% | +5.4% | +6.9% | +19.5% | +19.8% | +23.2% | +20.3% | +14.1% | +16.5% | +2.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.